Christopher TenHoor

1.6k total citations · 1 hit paper
12 papers, 1.1k citations indexed

About

Christopher TenHoor is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Christopher TenHoor has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Christopher TenHoor's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), T-cell and B-cell Immunology (3 papers) and Crystallization and Solubility Studies (2 papers). Christopher TenHoor is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), T-cell and B-cell Immunology (3 papers) and Crystallization and Solubility Studies (2 papers). Christopher TenHoor collaborates with scholars based in United States, Belgium and Germany. Christopher TenHoor's co-authors include Jennifer Dressman, Linda C. Burkly, Stuart J. Knechtle, Allan D. Kirk, John H. Fechner, S. John Swanson, D. Scott Batty, David M. Harlan, Justin D. Berning and Roxanne E. Baumgartner and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Blood.

In The Last Decade

Christopher TenHoor

12 papers receiving 1.0k citations

Hit Papers

Treatment with humanized monoclonal antibody against CD15... 1999 2026 2008 2017 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
    1999 666 citations Allan D. Kirk, Linda C. Burkly et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher TenHoor United States 7 474 256 247 199 140 12 1.1k
Somesh Choudhury United States 11 101 0.2× 129 0.5× 56 0.2× 45 0.2× 278 2.0× 15 625
Eli Dijkers Netherlands 10 57 0.1× 83 0.3× 59 0.2× 21 0.1× 232 1.7× 22 1.3k
Lynne P. Rutzky United States 12 91 0.2× 286 1.1× 198 0.8× 12 0.1× 261 1.9× 18 893
Michèle Masquelier Sweden 17 79 0.2× 8 0.0× 161 0.7× 32 0.2× 427 3.0× 34 962
Barbara C. Millar United Kingdom 17 162 0.3× 13 0.1× 57 0.2× 20 0.1× 286 2.0× 36 947
J A Belt United States 18 41 0.1× 104 0.4× 157 0.6× 9 0.0× 739 5.3× 28 1.8k
Willem J. Nooijen Netherlands 14 133 0.3× 6 0.0× 95 0.4× 113 0.6× 343 2.5× 21 1.6k
Wan‐Yun Huang China 13 34 0.1× 65 0.3× 65 0.3× 6 0.0× 157 1.1× 49 746
T Fujitsu Japan 10 165 0.3× 199 0.8× 99 0.4× 9 0.0× 128 0.9× 18 625
Natalia F. Krynetskaia United States 18 71 0.1× 35 0.1× 37 0.1× 6 0.0× 630 4.5× 28 1.3k

Countries citing papers authored by Christopher TenHoor

Since Specialization
Citations

This map shows the geographic impact of Christopher TenHoor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher TenHoor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher TenHoor more than expected).

Fields of papers citing papers by Christopher TenHoor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher TenHoor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher TenHoor. The network helps show where Christopher TenHoor may publish in the future.

Co-authorship network of co-authors of Christopher TenHoor

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher TenHoor. A scholar is included among the top collaborators of Christopher TenHoor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher TenHoor. Christopher TenHoor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kenniston, Jon, Stephen R. Comeau, Kateri Atkins, et al.. (2017). Structural basis for pH-insensitive inhibition of immunoglobulin G recycling by an anti-neonatal Fc receptor antibody. Journal of Biological Chemistry. 292(42). 17449–17460. 11 indexed citations
2.
Kenniston, Jon, Stephen R. Comeau, Ryan Faucette, et al.. (2015). Discovery and Characterization of a Highly Specific Antibody Inhibitor of Factor XIIa, and the Subsequent Generation of a Factor XIIa/Plasma Kallikrein Bispecific Antibody. Blood. 126(23). 2268–2268. 1 indexed citations
3.
Sexton, Daniel J., Jon Kenniston, Ryan Faucette, et al.. (2014). Comparison Of Plasma Kallikrein Inhibition By The Monoclonal Antibody Inhibitor DX-2930 To Endogenous C1-INH. Journal of Allergy and Clinical Immunology. 133(2). AB30–AB30. 1 indexed citations
4.
Faucette, Ryan, Malini Viswanathan, Greg Conley, et al.. (2013). Discovery and Characterization of a Fully Human Monoclonal Antibody Inhibitor of Plasma Kallikrein for the Treatment of Plasma Kallikrein-Mediated Edema. Journal of Allergy and Clinical Immunology. 131(2). AB32–AB32. 4 indexed citations
5.
Li, Zhaoyang, Christopher TenHoor, Thomas Marbury, et al.. (2010). Clinical Pharmacokinetics of Tonapofylline: Evaluation of Dose Proportionality, Oral Bioavailability, and Gender and Food Effects in Healthy Human Subjects. The Journal of Clinical Pharmacology. 51(7). 1004–1014. 6 indexed citations
6.
TenHoor, Christopher, et al.. (2002). Pharmacokinetics, Biologic Activity, and Tolerability of Alefacept by Intravenous and Intramuscular Administration. Journal of Pharmacokinetics and Pharmacodynamics. 29(5-6). 415–426. 28 indexed citations
7.
Cho, Clifford S., Linda C. Burkly, John H. Fechner, et al.. (2001). SUCCESSFUL CONVERSION FROM CONVENTIONAL IMMUNOSUPPRESSION TO ANTI-CD154 MONOCLONAL ANTIBODY COSTIMULATORY MOLECULE BLOCKADE IN RHESUS RENAL ALLOGRAFT RECIPIENTS1,2. Transplantation. 72(4). 587–597. 35 indexed citations
8.
Knechtle, Stuart J., John H. Fechner, Kevin Brunner, et al.. (2000). SUCCESSFUL CONVERSION FROM CONVENTIONAL IMMUNOSUPPRESSION TO ANTI-CD40 LIGAND THERAPY IN A NON-NUMAN PRIMATE MODEL.. Transplantation. 69(Supplement). S123–S123. 1 indexed citations
9.
Kirk, Allan D., Linda C. Burkly, D. Scott Batty, et al.. (1999). Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Medicine. 5(6). 686–693. 666 indexed citations breakdown →
10.
TenHoor, Christopher, et al.. (1996). Estimation of the Increase in Solubility of Drugs as a Function of Bile Salt Concentration. Pharmaceutical Research. 13(1). 163–167. 257 indexed citations
11.
TenHoor, Christopher & Barbra H. Stewart. (1995). Reconversion of Fosphenytoin in the Presence of Intestinal Alkaline Phosphatase. Pharmaceutical Research. 12(11). 1806–1809. 15 indexed citations
12.
TenHoor, Christopher, et al.. (1991). Solubility of Mefenamic Acid Under Simulated Fed- and Fasted-State Conditions. Pharmaceutical Research. 8(9). 1203–1205. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Somesh Choudhury Breakdown of academic impact, for papers by Eli Dijkers Breakdown of academic impact, for papers by Lynne P. Rutzky Breakdown of academic impact, for papers by Michèle Masquelier Breakdown of academic impact, for papers by Barbara C. Millar Breakdown of academic impact, for papers by J A Belt Breakdown of academic impact, for papers by Willem J. Nooijen Breakdown of academic impact, for papers by Wan‐Yun Huang Breakdown of academic impact, for papers by T Fujitsu Breakdown of academic impact, for papers by Natalia F. Krynetskaia
Rankless by CCL
2026